UKBizDB.co.uk

AKCEA THERAPEUTICS UK LTD.

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Akcea Therapeutics Uk Ltd.. The company was founded 8 years ago and was given the registration number 10304488. The firm's registered office is in READING. You can find them at 1st Floor West Davidson House, Forbury Square, Reading, Berkshire. This company's SIC code is 72110 - Research and experimental development on biotechnology.

Company Information

Name:AKCEA THERAPEUTICS UK LTD.
Company Number:10304488
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:01 August 2016
End of financial year:31 December 2022
Jurisdiction:England - Wales
Industry Codes:
  • 72110 - Research and experimental development on biotechnology

Office Address & Contact

Registered Address:1st Floor West Davidson House, Forbury Square, Reading, Berkshire, England, RG1 3EU
Country Origin:ENGLAND
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
1st Floor West, Davidson House, Forbury Square, Reading, England, RG1 3EU

Director22 December 2023Active
1664, Racho Sta. Fe, Ca 92067, United States,

Director02 June 2018Active
Akcea Therapeutics Uk Ltd, Regus Building, Wellington Way, Weybridge, United Kingdom, KT13 0TT

Director11 March 2020Active
1st Floor West, Davidson House, Forbury Square, Reading, England, RG1 3EU

Director01 August 2016Active
48a, Farnborough Road, Farnham, England, GU9 9AH

Director02 June 2018Active
1st Floor West, Davidson House, Forbury Square, Reading, England, RG1 3EU

Director31 March 2020Active
12, Pelhams Walk, Esher, England, KT10 8QD

Director02 June 2018Active

People with Significant Control

Ionis Pharmaceuticals Inc.
Notified on:12 October 2020
Status:Active
Country of residence:United States
Address:2855, Gazelle Court, Carlsbad, United States, 92010
Nature of control:
  • Ownership of shares 75 to 100 percent
  • Voting rights 75 to 100 percent
  • Right to appoint and remove directors
Akcea Therapeutics, Inc.
Notified on:01 August 2016
Status:Active
Country of residence:United States
Address:1209, Orange Street, City Of Wilmington, United States, 19801
Nature of control:
  • Ownership of shares 75 to 100 percent
  • Voting rights 75 to 100 percent
  • Significant influence or control

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (2 years ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (5 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (1 year ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (7 months remaining)

Copyright © 2025. All rights reserved.